These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2826606)

  • 1. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system.
    Arndt CA; Walsh TJ; McCully CL; Balis FM; Pizzo PA; Poplack DG
    J Infect Dis; 1988 Jan; 157(1):178-80. PubMed ID: 2826606
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clinical study of fluconazole against pulmonary mycosis. Effects of fluconazole on pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients].
    Nakashima M
    Jpn J Antibiot; 1989 Jan; 42(1):127-37. PubMed ID: 2540358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
    Troke PF; Andrews RJ; Marriott MS; Richardson K
    J Antimicrob Chemother; 1987 May; 19(5):663-70. PubMed ID: 3038824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with fluconazole of severe fungal infections in immunocompromised patients].
    Boulos M
    Rev Inst Med Trop Sao Paulo; 1993; 35(1):81-7. PubMed ID: 8278747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of cryptococcal disease in patients with AIDS.
    Bozzette SA
    Curr Clin Top Infect Dis; 1993; 13():250-68. PubMed ID: 8397913
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of fluconazole].
    Oka S; Tokitsu M; Mori H; Nakata H; Goto M; Goto H; Shimada K
    Jpn J Antibiot; 1989 Jan; 42(1):31-9. PubMed ID: 2540365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral aspergillosis: tissue penetration is the key.
    Schwartz S; Thiel E
    Med Mycol; 2009; 47 Suppl 1():S387-93. PubMed ID: 19255905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluconazole in the treatment of cryptococcosis].
    Tortorano AM; Viviani MA; Pagano A; Cargnel A; Gubertini G; Gatti L; Vaglia A
    G Ital Chemioter; 1988; 35(1-3):53-6. PubMed ID: 2855728
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
    Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of canine central nervous system cryptococcosis: management with fluconazole.
    Tiches D; Vite CH; Dayrell-Hart B; Steinberg SA; Gross S; Lexa F
    J Am Anim Hosp Assoc; 1998; 34(2):145-51. PubMed ID: 9507427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cryptococcal meningitis in mice with fluconazole.
    Palou de Fernandez E; Patino MM; Graybill JR; Tarbit MH
    J Antimicrob Chemother; 1986 Aug; 18(2):261-70. PubMed ID: 3019986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [AIDS fungus infections. Fluconazole--a new preparation in development].
    Keil TU
    Fortschr Med; 1989 Mar; 107(10):69-70. PubMed ID: 2541058
    [No Abstract]   [Full Text] [Related]  

  • 13. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
    Perfect JR; Durack DT
    J Antimicrob Chemother; 1985 Jul; 16(1):81-6. PubMed ID: 2995303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole penetration into cerebrospinal fluid in humans.
    Foulds G; Brennan DR; Wajszczuk C; Catanzaro A; Garg DC; Knopf W; Rinaldi M; Weidler DJ
    J Clin Pharmacol; 1988 Apr; 28(4):363-6. PubMed ID: 2839557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis.
    Reinwald M; Uharek L; Lampe D; Grobosch T; Thiel E; Schwartz S
    Bone Marrow Transplant; 2009 Aug; 44(4):269-70. PubMed ID: 19219077
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient.
    Mandras N; Roana J; Tullio V; Allizond V; Banche G; Scalas D; Fucale G; Cuffini AM
    J Chemother; 2011 Dec; 23(6):379-80. PubMed ID: 22233828
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy of fungal infections of the central nervous system.
    Speller DC
    Postgrad Med J; 1979 Sep; 55(647):615-8. PubMed ID: 523350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of BAY R3783 and its efficacy in the treatment of experimental cryptococcal meningitis.
    Wright KA; Perfect JR; Ritter W
    J Antimicrob Chemother; 1990 Sep; 26(3):387-97. PubMed ID: 2172199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS cryptococcosis: unusual aspects.
    Cochius JI; Burns RJ; Willoughby JO
    Clin Exp Neurol; 1989; 26():183-91. PubMed ID: 2561997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.